Short answer · Medically reviewed summary · Last updated: 2026-04-07
Coats Disease is considered a rare ocular condition, with estimated prevalence rates typically cited between 1 in 100,000 and 1 in 150,000, though these figures likely underestimate the true burden of the disease. Epidemiological Profile While definitive global incidence rates are difficult to establish, Coats Disease is widely recognized for its strong male predilection, with males accounting for approximately 80% to 90% of cases. The condition most commonly presents in pediatric patients, with an average age of onset around 8 to 16 years, although it can manifest at any stage of life, including infancy or adulthood. Challenges in Data Collection Accurate reporting for Coats Disease faces significant hurdles.
2 people with Coats Disease have shared their first-person experience on this question at DiseaseMaps.
Coats Disease is considered a rare ocular condition, with estimated prevalence rates typically cited between 1 in 100,000 and 1 in 150,000, though these figures likely underestimate the true burden of the disease.
While definitive global incidence rates are difficult to establish, Coats Disease is widely recognized for its strong male predilection, with males accounting for approximately 80% to 90% of cases. The condition most commonly presents in pediatric patients, with an average age of onset around 8 to 16 years, although it can manifest at any stage of life, including infancy or adulthood.
Accurate reporting for Coats Disease faces significant hurdles. Because the condition is often unilateral (affecting only one eye) and can remain asymptomatic in its early stages, many cases go undiagnosed until advanced stages like leukocoria (white pupil) occur. Furthermore, Coats Disease is frequently misdiagnosed as retinoblastoma, a far more common pediatric ocular malignancy, which leads to discrepancies in clinical reporting. There is currently no evidence of specific geographic or ethnic clusters, suggesting that the condition occurs sporadically worldwide.
While formal epidemiological databases provide clinical snapshots, patient-led platforms like DiseaseMaps.org offer essential real-world context. With 129 individuals currently sharing their journeys within our community, we gain a clearer understanding of the diagnostic delays and varied clinical presentations that formal literature sometimes misses. These community-reported experiences highlight that Coats Disease, while classified as "rare," impacts families profoundly, emphasizing the need for continued awareness and earlier screening protocols.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified ophthalmologist or retinal specialist regarding any medical condition.